Optimal infused CD34+ cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation.
Pasvolsky O, Marcoux C, Milton DR, Pal B, Tanner MR, Bashir Q, Srour S, Lee J, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Aljawai Y, Kebriaei P, Becnel MR, Lee HC, Patel KK, Thomas SK, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH.
Pasvolsky O, et al. Among authors: patel kk.
Blood Cancer J. 2024 Oct 31;14(1):189. doi: 10.1038/s41408-024-01165-w.
Blood Cancer J. 2024.
PMID: 39482325
Free PMC article.